Assura (LON:AGR)‘s stock had its “buy” rating restated by stock analysts at Liberum Capital in a research note issued on Thursday.

Separately, Peel Hunt reissued a “hold” rating on shares of Assura in a research note on Tuesday, October 2nd.

Shares of AGR opened at GBX 55.77 ($0.73) on Thursday. Assura has a 12-month low of GBX 55.95 ($0.73) and a 12-month high of GBX 67.30 ($0.88).

About Assura

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community.

Featured Story: How to Profit and Limit Losses With Stop Orders

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.